Works matching IS 17407745 AND DT 2008 AND VI 5 AND IP 3
Results: 14
Designing phase II studies in cancer with time-to-event endpoints.
- Published in:
- 2008
- By:
- Publication type:
- Journal Article
ERRATUM.
- Published in:
- Clinical Trials, 2008, v. 5, n. 3, p. 283, doi. 10.1177/1740774508094666
- Publication type:
- Article
Commentary on 'Designing phase II studies in cancer with time-to-event endpoints.'.
- Published in:
- Clinical Trials, 2008, v. 5, n. 3, p. 222, doi. 10.1177/1740774508092145
- By:
- Publication type:
- Article
Addressing the challenges of a cross-national investigation: lessons from the Pittsburgh-Pisa study of treatment-relevant phenotypes of unipolar depression.
- Published in:
- Clinical Trials, 2008, v. 5, n. 3, p. 253, doi. 10.1177/1740774508091965
- By:
- Publication type:
- Article
Bayesian adaptive design for targeted therapy development in lung cancer -- a step toward personalized medicine.
- Published in:
- Clinical Trials, 2008, v. 5, n. 3, p. 181, doi. 10.1177/1740774508091815
- By:
- Publication type:
- Article
Validity of diabetes self-reports in the Women's Health Initiative: comparison with medication inventories and fasting glucose measurements.
- Published in:
- Clinical Trials, 2008, v. 5, n. 3, p. 240, doi. 10.1177/1740774508091749
- By:
- Publication type:
- Article
Designing phase II studies in cancer with time-to-event endpoints.
- Published in:
- Clinical Trials, 2008, v. 5, n. 3, p. 209, doi. 10.1177/1740774508091748
- By:
- Publication type:
- Article
Alternative methods to evaluate trial level surrogacy.
- Published in:
- Clinical Trials, 2008, v. 5, n. 3, p. 194, doi. 10.1177/1740774508091677
- By:
- Publication type:
- Article
Overcoming challenges in designing and implementing a phase II randomized controlled trial using a presurgical model to test a dietary intervention in prostate cancer.
- Published in:
- Clinical Trials, 2008, v. 5, n. 3, p. 262, doi. 10.1177/1740774508091676
- By:
- Publication type:
- Article
Imputation methods for missing outcome data in meta-analysis of clinical trials.
- Published in:
- Clinical Trials, 2008, v. 5, n. 3, p. 225, doi. 10.1177/1740774508091600
- By:
- Publication type:
- Article
Balancing science and community concerns in resource-limited settings: Project Accept in rural Zimbabwe.
- Published in:
- Clinical Trials, 2008, v. 5, n. 3, p. 273, doi. 10.1177/1740774508091576
- By:
- Publication type:
- Article
Reformulating the hazard ratio to enhance communication with clinical investigators.
- Published in:
- Clinical Trials, 2008, v. 5, n. 3, p. 248, doi. 10.1177/1740774508091452
- By:
- Publication type:
- Article
Enhancing communication among data monitoring committees and institutional review boards.
- Published in:
- Clinical Trials, 2008, v. 5, n. 3, p. 277, doi. 10.1177/1740774508091262
- By:
- Publication type:
- Article
Commentary on 'Designing phase II studies in cancer with time-to-event endpoints.'.
- Published in:
- Clinical Trials, 2008, v. 5, n. 3, p. 223, doi. 10.1177/1740774508091748
- By:
- Publication type:
- Article